LENSAR (LNSR)
NASDAQ:LNSR
Want to see LNSR full AI Analyst Report?
LNSR Stock Chart & Stats
$11.61
-$0.54(-6.29%)
At close: 4:00 PM EST
$11.61
-$0.54(-6.29%)
Day’s Range― - ―
52-Week Range$5.06 - $13.67
Previous CloseN/A
Volume40.10K
Average Volume (3M)58.95K
Market Cap
$69.48M
Enterprise Value$60.28M
Total Cash (Recent Filing)$13.49M
Total Debt (Recent Filing)$2.57M
Price to Earnings (P/E)2.4
Beta0.90
Next Earnings
Aug 06, 2026EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.98
Shares Outstanding12,104,328
10 Day Avg. Volume51,870
30 Day Avg. Volume58,950
Financial Highlights & Ratios
PEG Ratio-0.79
Price to Book (P/B)-5.34
Price to Sales (P/S)2.38
P/FCF Ratio-9.32
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue1.04
Enterprise Value/Gross Profit2.31
Enterprise Value/Ebitda-7.42
Forecast
1Y Price Target
$8.50Price Target Upside-26.79% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.31
Revenue Forecast (FY)$63.05M
Bulls Say, Bears Say
Bulls Say
High Recurring Revenue MixRecurring revenue representing ~94% of sales and annualizing north of $50M creates a predictable, durable revenue base. This reduces capital-sales cyclicality, improves revenue visibility across quarters, and supports margin stability and reinvestment in service, R&D and commercialization as installed systems scale.
Installed Base ExpansionInstalled base growth to ~440 systems (ALLY ~205) plus a backlog of placements signals accelerating platform adoption. A growing installed base compounds recurring consumables, per-procedure fees and service revenue, raising customer lifetime value and creating durable revenue drivers independent of lumpy capital sales.
Solid Gross Margin ProfileMid-40s gross margins indicate healthy per-procedure economics and pricing power for the laser platform. These margins provide structural flexibility to fund SG&A rebuilds and R&D investment while preserving unit profitability, helping the business reach operating leverage as placements and utilization rise.
Bears Say
Persistent Negative Cash FlowOperating and free cash flow were deeply negative in the trailing period (-$12.2M), making cash generation the company's weakest element. Persistent cash burn limits strategic optionality, increases reliance on external financing or the $50M credit line, and raises execution risk for rebuilding sales and service capacity.
Weak Operating ProfitabilitySignificant negative operating margins (EBIT -22%, EBITDA -16%) show the business remains loss-making at the core. Reported GAAP profit reflects non-operating gains, not sustainable operations. Until operating margins improve, earnings quality and the path to positive free cash flow remain uncertain.
System-sales Volatility & Distributor DisruptionSystem (capital) sales are highly lumpy and fell sharply to ~$0.8M in the quarter, driven by distributor and international disruptions tied to the terminated transaction. Capital-sales volatility slows the ramp of recurring revenue and makes multi-quarter recovery timelines and revenue forecasting execution-sensitive.
LENSAR News
LNSR FAQ
What was LENSAR’s price range in the past 12 months?
LENSAR lowest stock price was $5.06 and its highest was $13.67 in the past 12 months.
What is LENSAR’s market cap?
LENSAR’s market cap is $69.48M.
When is LENSAR’s upcoming earnings report date?
LENSAR’s upcoming earnings report date is Aug 06, 2026 which is in 62 days.
How were LENSAR’s earnings last quarter?
LENSAR released its earnings results on May 08, 2026. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of N/A by $1.56.
Is LENSAR overvalued?
According to Wall Street analysts LENSAR’s price is currently Overvalued.
Does LENSAR pay dividends?
LENSAR does not currently pay dividends.
What is LENSAR’s EPS estimate?
LENSAR’s EPS estimate is -0.17.
How many shares outstanding does LENSAR have?
LENSAR has 12,104,328 shares outstanding.
What happened to LENSAR’s price movement after its last earnings report?
LENSAR reported an EPS of $1.56 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.839%.
Which hedge fund is a major shareholder of LENSAR?
Currently, no hedge funds are holding shares in LNSR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
LENSAR Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (-26.79% Downside)
$8.50 (-26.79% Downside)
Blogger Sentiment
Bullish
LNSR Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 172.0K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
56.49%
12-Months-Change
Fundamentals
Return on Equity
-514.92%
Trailing 12-Months
Asset Growth
-9.23%
Trailing 12-Months
Company Description
LENSAR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
LNSR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but stabilizing picture: operational fundamentals improved with durable recurring revenue growth (+9% YoY to $12.6M), installed-base expansion (+12% to ~440 systems) and rising procedure volumes (~54k). At the same time, near-term financials show weaknesses driven by a sharp decline in system revenue (~$0.8M vs $2.6M prior), a negative adjusted EBITDA (-$0.31M), modest cash ($13.5M), and one-time/non‑cash items that materially inflated GAAP net income. Management reports growing commercial momentum post-transaction (demos, distributor POs, product roadmap) but acknowledges it will take several quarters to rebuild international placements and fully restore prior growth rates. Overall, the call balances encouraging operational signs and strategic clarity against measurable near-term financial and timing challenges.View all LNSR earnings summariesLNSR Stock 12 Month Forecast
Average Price Target
$8.50
▼(-26.79% Downside)
Technical Analysis
Ownership Overview
12.92% Insiders
8.12% Mutual Funds
22.22% Other Institutional Investors
49.63% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---